WHAT WE BELIEVE

We are inspired by a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care.

 

In our investment criteria and process, we are informed by a Stanford-born methodology of health technology innovation known as Biodesign. Since 2001, Biodesign has proven to de-risk the process of new venture creation by applying a need-driven and value-based approach to reinventing healthcare with the help of technology.

 

We see our sweet spot at seeding founders who are marrying in-depth understanding of the complex network of healthcare system participants with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and seed founders determined to effectively and efficiently serve these participants on the european continent, where we are based, and internationally.

 

We invest in european companies as well as in selected non-european companies with ties to europe. Wherever they are, our goal is to help founders ready their companies to raise series A capital, and to access international markets.

We are committed

to need-driven founders with international ambitions.

more

We believe europe's growing technology ecosystem has global impact potential.

more

We have a special interest in innovative technology solutions and business models.

more

We understand the complexity of healthcare.

more

We have a bias for teams that are interdisciplinary & diverse along multiple dimensions.

more

We believe in the power of mentorship.

more

HEALTH TECHNOLOGY

with focus on data, computing, networks,
and other digital and deep technologies

SEED & SERIES A

we prefer to invest at the seed stage,

and follow-on in portfolio companies as they reach series A readiness

PAN-EUROPEAN

our ground zero is Barcelona,

our goal is to invest across the european continent and beyond

NEED-DRIVEN & VALUE-BASED

we uphold principles of Biodesign in our investment approach,

confident that need-driven technology ventures generate the highest value in healthcare and for their investors

© 2020 by NINA CAPITAL

 data-artwork by giorgia lupi